Focused on ocular oncology
General quality-of-life measures can miss treatment-specific concerns. PROM-UM is tailored to uveal melanoma care after brachytherapy.
Instrument PROM-UM
Patient-Reported Outcome Measure for Uveal Melanoma
A purpose-built outcome measure for post-brachytherapy uveal melanoma care.
PROM-UM captures patient experience after ocular brachytherapy in a format designed for research, quality improvement, and clinical implementation. Its development and validation are supported by peer-reviewed ocular oncology publications.
About
Learn about PROM-UM
PROM-UM was developed to make patient-reported outcomes more specific to ocular oncology care, especially the symptoms, function, and lived experience that matter after treatment.
Built for implementation
The instrument is intended for use in studies, registries, and care pathways where structured patient input can inform outcomes work.
Registration-supported use
Registration helps us understand how PROM-UM is being used, support appropriate implementation, and maintain version control.
Evidence
Development and validation
PROM-UM is supported by peer-reviewed work describing its development and psychometric validation for patients treated for uveal melanoma.
Development paper
Development of the PROM-UM instrument
Foundational publication supporting PROM-UM development for patient-reported outcomes in uveal melanoma care.
View articleValidation paper
Psychometric Results of a New Patient-Reported Outcome Measure for Uveal Melanoma Post-Brachytherapy Treatment: The PROM-UM
Validation study published in Cancers reporting PROM-UM psychometric results after plaque radiation treatment.
View articleLicensing
Choose the license that matches your use
A PROM-UM license is required before using, reproducing, distributing, translating, adapting, or electronically implementing the instrument.
Academic / non-profit
No fee
For investigator-led academic research, student projects, and non-profit quality improvement where PROM-UM is not part of a commercial product or sponsored trial.
Clinical use
$500/year USD
For routine care, institutional registries, clinical monitoring, and quality programs. Covers one clinical group of up to 20 PROM-UM users.
Commercial / trial use
$35-$70 USD per use
For industry-sponsored trials, contract research, digital health products, electronic platforms, or other commercial implementations.
Estimate
Approximate your fee
Use this guide for planning. All prices are listed in USD. Final fees and permitted uses are confirmed during registration.
| Use type | Typical examples | Indicative fee |
|---|---|---|
| Academic / non-profit | Unfunded or grant-funded academic studies, theses, non-profit QI | No fee |
| Clinical | Clinic groups, hospital programs, registry-based care monitoring | $500/year USD per group of 20 users |
| Commercial / clinical trial | Sponsored studies, CRO use, licensed electronic capture, product integration | $35-$70 USD per completed use |
Register
Register to use PROM-UM
Send a short registration request and we will confirm the appropriate license, fee category, and next steps.
Include these details
- Your name, institution, and contact email
- Intended use: academic, clinical, commercial, or trial
- Study, clinic, registry, or platform name
- Expected number of participants, sites, or users
- Whether electronic implementation or translation is planned